Teva: Starting to Pierce the Gloom

Regulatory approval for Teva Pharmaceutical Industries’ new treatment for Huntington’s disease offers some much-needed good news.

from WSJ.com: Markets http://ift.tt/2oFhAuX
via https://ifttt.com/ IFTTT